12 completed. 12 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 12 | Completed 12 |
Follow Zonisamide: new trials by email Literature Review of Zonisamide trials Research Report on Zonisamide
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Low vs. Standard Daily Doses of Antiepileptic Drugs in Newly Diagnosed, Previously Untreated Epilepsy(STANDLOW) Low dose carbamazepine, Standard dose carbamazepine, Low dose levetiracetam - Epilepsies, Partial | Phase 4 | Completed | Mario Negri Institute for Pharmacological Research | 58 | 2021-05-10 | 2025-07-08 |
| Evaluation of the Efficacy and Safety of Adjunctive Zonisamide vs Replacement With Zonisamide of the Last Added Antiepileptic Drug Adjunctive Zonisamide, Replacement with Zonisamide - Partial Seizures | Phase 4 | Completed | Eisai Inc. | 200 | 2009-09-01 | 2014-07-14 |
| Comparing The Effect On Cognition Of Adjunctive Therapy With Zonisamide Versus Sodium Valproate Zonisamide, Sodium valproate - Epilepsy | Phase 4 | Completed | Eisai Limited | 2 | 2008-06-01 | 2015-11-03 |
| ZAGAL Study: Evaluating Effectiveness and Tolerability of Zonisamide as Adjunctive Therapy in Patients With Partial Onset Seizures Treated With Two Antiepileptic Drugs Zonisamide - Epilepsy | Phase 4 | Completed | Eisai Inc. | 32 | 2008-04-01 | 2013-05-13 |
| Open-label, Multi-center Trial of Zonisamide as Adjunctive Therapy in Patients With Uncontrolled Partial Epilepsy zonisamide - Epilepsy | Phase 4 | Completed | Eisai Korea Inc. | 121 | 2008-02-29 | 2022-01-04 |
| A Prospective, Observational Study On The Effectiveness Of New Antiepileptic Drugs As First Bitherapy In The Daily Clinical Practice Gabapentin, Lamotrigine, Levetiracetam, Pregabalin, Oxcarbacepine, Tiagabine, Topiramate, Zonisamide - Focal Epilepsy | Phase 4 | Completed | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 111 | 2007-05-01 | 2021-01-25 |
| Zonisamide vs. Placebo in the Treatment of Alcohol Dependence zonisamide, Placebo - Alcoholism, Alcohol Abuse | Phase 4 | Completed | UConn Health | 40 | 2006-07-01 | 2010-10-15 |
| Comparative Study of Zonisamide and Carbamazepine as an Initial Monotherapy: Efficacy and Safety Evaluation zonisamide, carbamazepine - Epilepsy | Phase 4 | Completed | Eisai Korea Inc. | 200 | 2006-05-31 | 2022-01-04 |
| Low and High Dose Zonisamide in Children as Monotherapy zonisamide low dose group, zonisamide high dose group - Epilepsy | Phase 4 | Completed | Eisai Korea Inc. | 125 | 2006-03-01 | 2012-07-31 |
| Open Label, Zonegran (Zonisamide) In Partial Onset Seizures Zonegran - Epilepsy | Phase 4 | Completed | Eisai Limited | 1000 | 2005-10-01 | 2016-01-08 |
| A Multicenter Comparative Trial of Zonisamide and Topiramate as Initial Monotherapy in Untreated Epilepsies Zonisamide, Topiramate - Epilepsy | Phase 4 | Completed | Eisai Korea Inc. | 140 | 2005-09-01 | 2009-09-02 |
| Zonegran for the Treatment of Weight Gain Associated With Psychotropic Medication Use: A Placebo-Controlled Trial Zonegran, Placebo - Obesity | Phase 4 | Completed | Tuscaloosa Research & Education Advancement Corporation | 20 | 2003-05-01 | 2012-09-03 |
Epilepsy (8) · Epilepsies, Partial (2) · Seizures (2) · Alcoholism (1) · Obesity (1)
Eisai Korea Inc. (4) · Eisai Inc. (2) · Eisai Limited (2) · Mario Negri Institute for Pharmacological Research (1) · Pfizer's Upjohn has merged with Mylan to form Viatris Inc. (1) · Tuscaloosa Research & Education Advancement Corporation (1) · UConn Health (1)
South Korea (4) · Italy (3) · Austria (2) · United States (2) · Denmark (1) · Finland (1) · France (1) · Germany (1) · Norway (1) · Spain (1) · United Kingdom (1)
Jihee Mun (4) · Albert J. Arias, MD (1) · Andrew Yeates (1) · Dr. Tone Bjaaland (1) · Ettore Beghi, MD (1) · Jesus De Rosendo (1) · Lori L Davis, MD (1) · Salvatore Striano (1)
2005 (1), M01RR006192 (1), P50AA003510 (1)